Baxter international inc. (nyse:bax) completed the acquisition of cheetah medical, inc. from highcape partners, l.p. and others.

Baxter international inc. (nyse:bax) entered into a definitive agreement to acquire cheetah medical, inc. from highcape partners, l.p. and others for $230 million on september 10, 2019. the transaction consists of an upfront cash consideration of $190 million, with potential for an additional $40 million based on clinical and commercial milestones. cheetah medical employees will join baxter international. the acquisition is subject to customary closing conditions including regulatory approvals and is expected to close in the fourth quarter of 2019. baxter international expects the acquisition to be immaterial to earnings in 2019 and 2020. baxter international inc. (nyse:bax) completed the acquisition of cheetah medical, inc. from highcape partners, l.p. and others on november 7, 2019.
BAX Ratings Summary
BAX Quant Ranking